IBM Signs a $240 Million AI Deal. Here’s What It Means for the Stock

Key Stats for IBM Stock

• Past week performance: +2.1%
• 52-week range: $199 to $332
• Valuation model target price: $281
• Implied upside: 20.1% over 2.4 years

Value your favorite stocks like IBM with 5 years of analysts’ forecasts using TIKR (It’s free) >>>

Betting Big on Enterprise AI After a Rough Quarter

International Business Machines (IBM) is making its most aggressive push yet into enterprise AI. The timing is notable. On August 13, IBM announced a strategic partnership with OpenAI to embed GPT 5.6, Codex, and ChatGPT Work into IBM Consulting Advantage, its AI powered delivery platform. The deal targets industry specific solutions across finance, government, and retail. It also includes a dedicated OpenAI practice staffed by thousands of certified consultants.

The partnership arrived weeks after IBM lowered its 2026 revenue forecast following a weak second quarter. CEO Arvind Krishna acknowledged the miss directly in a letter to investors. He wrote that supply constraints and pricing pressure require the team to execute perfectly, and this quarter it faltered. Still, Krishna has consistently framed AI as a long term growth driver. He noted on the earnings call that AI adoption is complementing, not replacing, demand for IBM’s mainframe business.

IBM followed the OpenAI news two days later with a separate $240 million deal with Together AI. That partnership will build a large scale AI inference cluster on IBM Cloud using Nvidia hardware. The cluster is expected to go live in early 2027, giving IBM another path into the fast growing AI inference market.

If IBM stock keeps climbing on partnership headlines, the real test will be whether these deals convert into measurable revenue. Going forward, IBM’s next few earnings reports need to show whether generative AI backlog, which already exceeds 30% of total backlog, is translating into faster software growth.

See analysts’ growth forecasts and price targets for IBM (It’s free) >>>

Is IBM Stock Still Cheap After the OpenAI Deal?

Under valuation model assumptions realized through 12/31/28, the stock is modeled using:

• Revenue Growth (CAGR): 4.4%
• Operating Margins: 22.1%
• Exit P/E Multiple: 18.3x

Based on these inputs, the model estimates a target price of $281, implying 20.1% total upside from the current share price and an annualized return of 8.1% over the next 2.4 years.

IBM’s 4.4% revenue growth assumption sits close to the company’s own guidance of 4% to 5% growth for 2026. So this model is not pricing in a dramatic jump from the new AI partnerships just yet. Instead, it treats those deals as supportive of the existing trajectory.

The 22.1% operating margin assumption reflects IBM’s shift toward higher margin software, which grew 5% last quarter even as infrastructure sales fell 7%. That divergence is central to the bull case. If software keeps gaining share, margins should expand without much help from the top line.

Against peers, IBM’s 18.3 times exit multiple looks rich next to Accenture (ACN), which now trades around 12 times forward earnings after its stock fell more than 50% in 2026. Accenture’s revenue growth guidance of 3% to 5% nearly matches IBM’s own assumption. Yet the market prices Accenture at a steep discount, reflecting deeper worries about AI disrupting traditional consulting.

Compare IBM’s AI strategy against its own history (Free with TIKR) >>>

IBM Against the Enterprise Technology Field

Accenture (ACN) is IBM’s closest comparison in enterprise AI consulting, and the contrast right now is stark. Accenture’s stock has fallen more than 50% in 2026 after a weak quarter and reduced bookings. Its forward P/E has compressed to roughly 12 times, well below IBM’s 18.3 times assumption, even though both guide to similar mid single digit revenue growth.

That gap partly reflects IBM’s broader mix. Unlike Accenture, IBM pairs consulting with proprietary software, mainframe hardware, and cloud infrastructure. So it has multiple ways to monetize AI adoption beyond billable hours. IBM’s software segment growing 5% while infrastructure fell 7% shows a business actively rebalancing toward higher margin revenue.

CrowdStrike (CRWD) offers a useful contrast from cybersecurity, an area IBM also competes in. CrowdStrike trades at a much richer valuation, around 175 times forward earnings, supported by annual recurring revenue growth near 24%. That gap shows how differently the market prices pure play AI security growth versus IBM’s more diversified, lower growth positioning.

Set against both peers, IBM sits in the middle. It is cheaper and more diversified than CrowdStrike, but it commands a premium over Accenture, a traditional consulting peer that is currently out of favor.

Track quantum funding, domestic chip capacity, and government procurement to gauge the policy payoff for IBM >>>

What’s Driving IBM Stock Going Forward?

The clearest near term catalyst is whether the OpenAI and Together AI deals show up in reported revenue. Neither deal disclosed financial terms or named customers, so the next two earnings reports should offer the first real evidence.

Generative AI backlog is worth tracking closely. Management disclosed that AI now represents more than 30% of total backlog. Continued growth there would validate the strategic bet, even before it fully shows up in quarterly revenue.

Quantum computing progress adds a longer horizon catalyst. IBM connected its first modular cryogenic systems this month as part of its roadmap toward fault tolerant quantum computing by 2029. Neither initiative moves near term numbers, but both reinforce IBM’s positioning as a differentiated platform.

Finally, the pace of infrastructure recovery matters. Sales fell 7% last quarter, and any stabilization there would support the margin expansion assumption baked into the model above.

See how IBM’s AI bets could reshape its next target price (Free with TIKR) >>>

Should You Invest in International Business Machines?

The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.

Pull up IBM, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.

You can build a free watchlist to track IBM alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.

Analyze IBM stock on TIKR Free→

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!